[Skip to Content]
[Skip to Content Landing]
May 18, 1963

Life Insurance for the Young Cardiovascular Patient

Author Affiliations


John Hancock Mutual Life Insurance Company, Mutual Benefit Life Insurance Company, and New England Mutual Life Insurance Company.; Connecticut General Life Insurance Company, Equitable Life Assurance Society of the United States, Metropolitan Life Insurance Company, Mutual Life Insurance Company of New York, New York Life Insurance Company, Prudential Life Insurance Company, and The Travelers.

JAMA. 1963;184(7):593-594. doi:10.1001/jama.1963.73700200014025c

LIFE INSURANCE has been difficult to obtain for the young individual who has had a cardiovascular complaint. In the not too distant past, the patient with an innocent heart murmur often was not reliably differentiated from the child with rheumatic heart disease or a congenital cardiovascular defect because of the inadequacy of diagnostic techniques. In addition, prior to 1939, there was no method of complete correction of a cardiovascular defect.1 As a result, life insurance companies were reluctant to insure these patients.2

The accuracy of diagnosis and the effectiveness of therapy of cardiovascular disease have undergone remarkable changes in the past 2 decades. Facilities are now available which permit even complex abnormalities to be diagnosed with precision. Furthermore, advances in cardiovascular surgery have, in many cases, improved the prognosis to such an extent that these patients can look forward to living normal lives. For these reasons, it seemed

First Page Preview View Large
First page PDF preview
First page PDF preview